Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 5
Abstract
Introduction. The early establishment of an etiology for acute liver failure (ALF) in infants is essential for the start of adequate treatment in the shortest timeframe possible.Aim. To identify markers of inherited metabolic disease on admission in children under two years of age with ALF.Material and methods. A retrospective review of the medical records of all children (< 2 years old) with ALF admitted to the pediatric hepatology or intensive care units of a tertiary center over a twenty-three year period (January 1989 to December 2011) was done. Patients were divided into two groups: with (group A) or without (group B) a metabolic etiology. Clinical and laboratory parameters on admission were compared.Results. Twenty-three children met inclusion criteria. Twelve had ALF of metabolic origin (group A). The median age in this group was 2.25 (Q1-Q3: 0.63-4.65) months and in group B 8.0 (Q1-Q3: 1.5-15) months. History of failure to thrive and/or vomiting was more frequent in group A (p = 0.022). Age, gender, encephalopathy and left ventricular hypertrophy were similar in both groups (p = 0.147, p = 1.000, p = 0.637, p = 1.000, respectively). Laboratory tests on admission (plasma lactate, ammonia, cholesterol, phosphate, INR, glucose, bilirubin,ALT, base excess and the presence of reducing substances in urine) showed no statistically significant differences between groups.Conclusion. This study showed that although infants with inborn errors of metabolism showed a trend towards lower age at presentation, the only marker of inherited metabolic disease found on admission was history of vomiting and/or failure to thrive.
Authors and Affiliations
Ana Brett, Carla Pinto, Leonor Carvalho, Paula Garcia, Luísa Diogo, Isabel Gonçalves
Keywords
Related Articles
- EP ID EP78320
- DOI -
- Views 130
- Downloads 0
Primary prophylaxis with ciprofloxacin in cirrhotic patients with ascites: a randomized, double blind study
Introduction and aim. There is scarce information about primary prophylaxis in cirrhotic patients. The aim was to assess the efficacy of ciprofloxacin for primary prophylaxis for bacterial infections in patients with cir...
New strategies for treating hepatic encephalopathy
Prophylactic and curative effects of purslane on bile duct ligation-induced hepatic fibrosis in albino rats
Introduction. Hepatic fibrosis is a common pathological process of chronic liver injury. Oxidative stress and inflammation may have prognostic value in disease progression. Objective. To examine the implication of both a...
Percutaneous liver biopsy – 2 decades of experience in a public hospital in the South of Brazil
Introduction. Liver biopsy is a complementary method for diagnosis, staging and therapeutic guidance in liver diseases, where chronic viral hepatitis are the most acknowledged causes for the indication of histopathologic...
Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran
Objective. To determine intrafamilial seropositivity of HBV and HCV and to compare them in families of infected persons with HBV and HCV in Hamadan clinic of hepatitis. Material and methods. In this analytic cross-sectio...